XP
XP INC, CL-A
XP INC, CL-A historical holders
total: 8
Oaktree Capital Management XP INC, CL-A transactions over time
- Total transactions:
- 9
- New positions:
- 3
- Sold out:
- 2
- Added:
- 1
- Reduced:
- 3
- Held since:
- 2025 Q3
- Held for:
- 3 quarters
- Latest activity:
- 2026 Q1
Howard Marks has been an institutional investor in XP INC, CL-A (XP) since 2021 Q4. According to 2026 Q1 report, Howard Marks holds 3,172,009 shares with a market value of roughly $60.40M representing 1.02% of their equity portfolio. The fund/company first acquired XP in 2021 Q4, initially purchasing 161,799 shares. Howard Marks later completely sold out the position and reinvested in XP again in 2025 Q3. Since the initial investment, Oaktree Capital Management has made 8 more transactions in this position.
Does Howard Marks still hold XP?
Yes, Howard Marks continues to hold XP INC, CL-A (XP). According to their 2026 Q1 report, they maintain a position of 3,172,009 shares valued at approximately $60.40M, representing 1.02% of their equity portfolio.
When did Howard Marks first invest in XP?
Howard Marks first invested in XP INC, CL-A (XP) in 2021 Q4 at the reported quarter-end price of $28.74 per share, acquiring 161,799 shares in their initial purchase.
What is Howard Marks's average cost basis for XP?
Based on historical transaction data, Howard Marks's estimated cost basis for XP INC, CL-A (XP) is approximately $17.85 per share. This represents their average reported price* across all buy transactions.
Has Howard Marks reinvested in XP after selling?
Yes, Howard Marks has shown renewed interest in XP INC, CL-A (XP). After completely selling their position, they reinitiated an investment in 2025 Q3, demonstrating continued conviction in this ticker.
Estimated cost basis*
- Weighted AVG buy price:
- $17.85
- Weighted AVG sell price:
- $19.04
XP transactions history by Oaktree Capital Management
9 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2026 Q1
|
1.02%
|
3,172,009
|
$19.04
|
$60,395,051
|
-4.46% (-148,150)
|
-0.05%
|
|
2025 Q4
|
0.88%
|
3,320,159
|
$16.37
|
$54,351,002
|
+63.32% (+1,287,282)
|
+0.34%
|
|
2025 Q3
|
0.64%
|
2,032,877
|
$18.79
|
$38,197,758
|
new
|
+0.64%
|
|
2024 Q4
|
0.00%
|
0
|
$17.94
|
|
-100% (-510,764)
|
-0.15%
|
|
2024 Q3
|
0.15%
|
510,764
|
$17.94
|
$9,163,106
|
new
|
+0.15%
|
|
2023 Q1
|
0.00%
|
0
|
$15.34
|
|
-100% (-120,289)
|
-0.02%
|
|
2022 Q3
|
0.03%
|
120,289
|
$19.00
|
$2,286,000
|
-7.58% (-9,872)
|
-0%
|
|
2022 Q1
|
0.04%
|
130,161
|
$30.09
|
$3,917,000
|
-19.55% (-31,638)
|
-0.01%
|
|
2021 Q4
|
0.05%
|
161,799
|
$28.74
|
$4,650,000
|
new
|
+0.05%
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.